138 related articles for article (PubMed ID: 1394184)
1. Antilymphoma activity of human gamma delta T-cells in mice with severe combined immune deficiency.
Malkovska V; Cigel FK; Armstrong N; Storer BE; Hong R
Cancer Res; 1992 Oct; 52(20):5610-6. PubMed ID: 1394184
[TBL] [Abstract][Full Text] [Related]
2. Human peripheral gamma delta T cells are stimulated by Daudi Burkitt's lymphoma and not by any other Burkitt's lymphoma tested.
Kaur I; de Jong J; Schell K; Hank J; Fisch P; Sondel PM
Cell Immunol; 1994 Jun; 156(1):54-61. PubMed ID: 8200042
[TBL] [Abstract][Full Text] [Related]
3. MHC-unrestricted cytotoxic and proliferative responses of two distinct human gamma/delta T cell subsets to Daudi cells.
Fisch P; Oettel K; Fudim N; Surfus JE; Malkovsky M; Sondel PM
J Immunol; 1992 Apr; 148(8):2315-23. PubMed ID: 1532810
[TBL] [Abstract][Full Text] [Related]
4. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors.
Halary F; Peyrat MA; Champagne E; Lopez-Botet M; Moretta A; Moretta L; Vié H; Fournié JJ; Bonneville M
Eur J Immunol; 1997 Nov; 27(11):2812-21. PubMed ID: 9394804
[TBL] [Abstract][Full Text] [Related]
5. Close correlation between Daudi and mycobacterial antigen recognition by human gamma delta T cells and expression of V9JPC1 gamma/V2DJC delta-encoded T cell receptors.
Davodeau F; Peyrat MA; Hallet MM; Gaschet J; Houde I; Vivien R; Vie H; Bonneville M
J Immunol; 1993 Aug; 151(3):1214-23. PubMed ID: 8393042
[TBL] [Abstract][Full Text] [Related]
6. Human V gamma 9-V delta 2 T cell receptor-gamma delta lymphocytes show specificity to Daudi Burkitt's lymphoma cells.
Sturm E; Braakman E; Fisch P; Vreugdenhil RJ; Sondel P; Bolhuis RL
J Immunol; 1990 Nov; 145(10):3202-8. PubMed ID: 2146317
[TBL] [Abstract][Full Text] [Related]
7. Activation of human gamma delta T cells by Mycobacterium tuberculosis and Daudi lymphoma cells: differential regulatory effect of IL-10 and IL-12.
Marx S; Wesch D; Kabelitz D
J Immunol; 1997 Mar; 158(6):2842-8. PubMed ID: 9058820
[TBL] [Abstract][Full Text] [Related]
8. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
Hernandez-Ilizaliturri FJ; Jupudy V; Ostberg J; Oflazoglu E; Huberman A; Repasky E; Czuczman MS
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5866-73. PubMed ID: 14676108
[TBL] [Abstract][Full Text] [Related]
9. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of Fab' and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites.
Ghetie MA; Richardson J; Tucker T; Jones D; Uhr JW; Vitetta ES
Cancer Res; 1991 Nov; 51(21):5876-80. PubMed ID: 1933855
[TBL] [Abstract][Full Text] [Related]
11. Human peripheral gamma delta T cells recognize hsp60 molecules on Daudi Burkitt's lymphoma cells.
Kaur I; Voss SD; Gupta RS; Schell K; Fisch P; Sondel PM
J Immunol; 1993 Mar; 150(5):2046-55. PubMed ID: 8094731
[TBL] [Abstract][Full Text] [Related]
12. V delta 1+ subset of human gamma delta T cells responds to ligands expressed by EBV-infected Burkitt lymphoma cells and transformed B lymphocytes.
Häcker G; Kromer S; Falk M; Heeg K; Wagner H; Pfeffer K
J Immunol; 1992 Dec; 149(12):3984-9. PubMed ID: 1334108
[TBL] [Abstract][Full Text] [Related]
13. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
[TBL] [Abstract][Full Text] [Related]
15. Requirement for CD4+ T cells in the gammadelta T cell proliferative response to Daudi Burkitt's lymphoma.
Burns J; Lobo S; Bartholomew B
Cell Immunol; 1996 Nov; 174(1):19-24. PubMed ID: 8929450
[TBL] [Abstract][Full Text] [Related]
16. Functional and phenotypic differences between CD4+ and CD4- T cell receptor-gamma delta clones from peripheral blood.
Spits H; Paliard X; Vandekerckhove Y; van Vlasselaer P; de Vries JE
J Immunol; 1991 Aug; 147(4):1180-8. PubMed ID: 1831219
[TBL] [Abstract][Full Text] [Related]
17. Recognition and destruction of virus-infected cells by human gamma delta CTL.
Bukowski JF; Morita CT; Brenner MB
J Immunol; 1994 Dec; 153(11):5133-40. PubMed ID: 7963571
[TBL] [Abstract][Full Text] [Related]
18. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency.
Murphy WJ; Conlon KC; Sayers TJ; Wiltrout RH; Back TC; Ortaldo JR; Longo DL
J Immunol; 1993 Apr; 150(8 Pt 1):3634-42. PubMed ID: 8468492
[TBL] [Abstract][Full Text] [Related]
19. Protective immunity induced by B7/CD28-costimulated gamma delta T cells to the EL-4 lymphoma in allogenic athymic mice.
Li Y; Newby SA; Johnston JV; Hellström KE; Chen L
J Immunol; 1995 Dec; 155(12):5705-10. PubMed ID: 7499857
[TBL] [Abstract][Full Text] [Related]
20. Activated peripheral blood mononuclear cells from patients receiving subcutaneous interleukin-2 following autologous stem cell transplantation prolong survival of SCID mice bearing human lymphoma.
Katsanis E; Weisdorf DJ; Miller JS
Bone Marrow Transplant; 1998 Jul; 22(2):185-91. PubMed ID: 9707028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]